PARADIGM BIOPHARMACEUTICALS LTD has a total of 28 patent applications. It increased the IP activity by 700.0%. Its first patent ever was published in 2008. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are P2 SCIENCE APS, FEHER JANOS and MUNDIPHARMA PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United States | 4 | |
#4 | Canada | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | China | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Diagnosis and surgery | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Rennie Paul | 19 |
#2 | Krishnan Ravi | 19 |
#3 | Coombe Deirdre Roma | 4 |
#4 | Paspaliaris Vasilis | 3 |
#5 | Langan Brett | 3 |
#6 | Kett Warren Charles | 2 |
#7 | Kett Warren | 2 |
#8 | Paspaliaris Bill | 1 |
#9 | Ghosh Peter | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020073089A1 | Treatment of pain with polysulfated polysaccharides | |
SG11202007561TA | Treatment of post-operative joint pain with polysulfated polysaccharides | |
CN111417399A | Polysulfated polysaccharides for the treatment of myelopathy | |
EP3052616A1 | A method of producing exosomes | |
AU2012300181A1 | Peptides for use in the treatment of IL-1 related diseases and conditions | |
EP2164501A1 | Sulphated xylans for treatment or prophylaxis of respiratory diseases |